Patents by Inventor Antonio Capone
Antonio Capone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12010013Abstract: A device for controlling network routing configurations is configured to obtain a predicted traffic matrix and a plurality of traffic matrices, and to determine, from a plurality of clusters, arranged in a hierarchical structure over the predicted traffic matrix and the plurality of traffic matrices, a first cluster allocated to a lower hierarchy level that contains the predicted traffic matrix. Each of the clusters is associated with a routing configuration, and the plurality of clusters are allocated to at least two different hierarchy levels. The device selects, from the plurality of clusters, a second cluster allocated to a higher hierarchy level that includes at least the first cluster and a third cluster allocated to the lower hierarchy level that contains a current traffic matrix, determine a second routing configuration associated with the second cluster; and activate the second routing configuration as a network routing configuration.Type: GrantFiled: August 6, 2021Date of Patent: June 11, 2024Assignee: Huawei Technologies Co., Ltd.Inventors: Stefano Paris, Jeremie Leguay, Wei Chen, Qian Cao, Davide Sanvito, Antonio Capone, Ilario Filippini
-
Publication number: 20240000890Abstract: A method for neural regeneration is provided at specific situses that include the inner ear and retina, where Ganglion cells respond to the method through at least stimulation of such cells. As a result, the method provides for reversing clinical conditions associated with the nerve degradation or disease. Specific clinical conditions reversed at least in part through nerve regeneration include hearing loss, tinnitus, and a host of neurotrophic retinopathies, diabetes, Norrie disease, and others. Nerve regeneration is accomplished with a protein that is a truncated synthetic polypeptide related to native norrin protein. Truncated norrin proteins have a longer half-life in the situs than native norrin proteins. A version of the truncated norrin protein lacks a cleavage site for a subject protease enzyme that cleaves native norrin proteins and thereby shortens the useful life of the therapeutic protein.Type: ApplicationFiled: January 11, 2021Publication date: January 4, 2024Applicant: Retinal Solutions, LLCInventors: Kimberly Drenser, Michael T. Trese, Antonio Capone
-
Publication number: 20230126239Abstract: A method is provided to limit inter-cellular leakage between cells in retinal or choroidal vasculature. As a result, an ocular disorder in which ocular or choroidal edema occurs based on leakage of the Adherens Junctions or Tight Junctions is readily treated. The method is particularly well-suited for usage in response to the blood-retinal barrier (BRB) compromise. A method is also provided for the reduction of plasmalemma vesicle-associated protein (PLVAP), which causes transcytosis and pinicytotic leakage. In a particular application, fluid collection under retinal pigment epithelial cells in wet macular degeneration is reduced; a condition currently without effective clinical treatments.Type: ApplicationFiled: March 8, 2021Publication date: April 27, 2023Applicant: Retinal Solutions, LLCInventors: Kimberly Drenser, Michael T. Trese, Antonio Capone
-
Patent number: 11198714Abstract: A synthetic truncated norrin protein is provided. The synthetic truncated norrin protein is a ?24 residue N-terminus norrin truncate relative to SEQ ID. NO. 1 that retains the cysteine-knot motif and frizzled-4 binding properties and has a mutation in the cysteine-knot motif in at least one position 81-90 of SEQ ID. NO. 1 that interferes with protease cleavage of the resulting protein thereby extending the biological half-life thereof in vivo relative to native norrin.Type: GrantFiled: March 25, 2020Date of Patent: December 14, 2021Assignee: RETINAL SOLUTIONS LLCInventors: Kimberly Drenser, Michael T. Trese, Antonio Capone
-
Publication number: 20210367882Abstract: A device for controlling network routing configurations is configured to obtain a predicted traffic matrix and a plurality of traffic matrices, and to determine, from a plurality of clusters, arranged in a hierarchical structure over the predicted traffic matrix and the plurality of traffic matrices, a first cluster allocated to a lower hierarchy level that contains the predicted traffic matrix. Each of the clusters is associated with a routing configuration, and the plurality of clusters are allocated to at least two different hierarchy levels. The device selects, from the plurality of clusters, a second cluster allocated to a higher hierarchy level that includes at least the first cluster and a third cluster allocated to the lower hierarchy level that contains a current traffic matrix, determine a second routing configuration associated with the second cluster; and activate the second routing configuration as a network routing configuration.Type: ApplicationFiled: August 6, 2021Publication date: November 25, 2021Inventors: Stefano PARIS, Jeremie LEGUAY, Wei CHEN, Qian CAO, Davide SANVITO, Antonio CAPONE, Ilario FILIPPINI
-
Patent number: 11041863Abstract: A method for determining the necessity of a pre-term birth treatment is provided based on obtaining a biological sample from a subject. The biological sample is analyzed for the presence of (P33S;P168S) Frizzled4 (Fzd4) gene variation. The subject or a fetus thereof is then treated for a proclivity to pre-term birth. The Fzd4 protein itself can also be analyzed for the (P33S;P168S) Fzd4 mutation.Type: GrantFiled: July 21, 2017Date of Patent: June 22, 2021Assignee: RETINAL SOLUTIONS LLCInventors: Kimberly Drenser, Michael T. Trese, Antonio Capone
-
Patent number: 10799557Abstract: A method of tightening inter-cellular junctions in endothelial or epithelial cells includes exposing the endothelial or epithelial cells to a norrin in concert with an anti-VEGF agent. Upon sufficient contact time, for norrin to selectively up-regulate gene expression of Cadherin or claudin-5 in the endothelial or epithelial cells, the inter-cellular junctions are tightened.Type: GrantFiled: December 12, 2018Date of Patent: October 13, 2020Assignee: RETINAL SOLUTIONS LLCInventors: Michael T. Trese, Antonio Capone, Kimberly Drenser
-
Publication number: 20200299344Abstract: A synthetic truncated norrin protein is provided. The synthetic truncated norrin protein is a ?24 residue N-terminus norrin truncate relative to SEQ ID. NO. 1 that retains the cysteine-knot motif and frizzled-4 binding properties and has a mutation in the cysteine-knot motif in at least one position 81-90 of SEQ ID. NO. 1 that interferes with protease cleavage of the resulting protein thereby extending the biological half-life thereof in vivo relative to native norrin.Type: ApplicationFiled: March 25, 2020Publication date: September 24, 2020Applicant: Retinal Solutions, LLCInventors: Kimberly Drenser, Michael T. Trese, Antonio Capone
-
Patent number: 10708179Abstract: The apparatus (SW) has a plurality of input/output ports (P1, P2, P3, P4, P5) for receiving and transmitting data packets, and comprises a data packets handling circuitry (DPL) arranged to forward data packets between the input/output ports (P1, P2, P3, P4, P5) and an internal apparatus controller (CPL) arranged to control the data packet handling circuitry (DPL); the apparatus controller (CPL) is arranged to store (MEM) at least one state transition table (TT) to be used for controlling the forwarding of data packets by the data packets handling circuitry (DPL); the apparatus controller (CPL) is arranged to use the state transition table (TT) for implementing at least one finite state machine (FSM); the apparatus controller (CPL) is arranged to use the state transition table (TT) for handling separately distinct incoming data packets flows through corresponding distinct instances of finite state machine; the state transition table (TT) corresponds to the combination of a state table (ST), a condition table (Type: GrantFiled: March 27, 2017Date of Patent: July 7, 2020Assignee: CONSORZIO NAZIONALE INTERUNIVERSITARIO PER LE TELECOMUNICAZIONI (CNIT)Inventors: Giuseppe Bianchi, Salvatore Pontarelli, Marco Bonola, Carmelo Cascone, Davide Sanvito, Antonio Capone
-
Patent number: 10703787Abstract: A method of tightening inter-cellular junctions in retinal or choroidal vessel cells includes exposing the retinal or choroidal vessel cells to norrin and an anti-VEGF agent. Upon sufficient contact time, for norrin to selectively up-regulate gene expression of VE-cadherin or claudin-5 in the retinal or choroidal vessel cells, the inter-cellular junctions are tightened. The method is also suitable for treating retinal pigment epithelial cells in wet macular degeneration.Type: GrantFiled: November 6, 2018Date of Patent: July 7, 2020Assignee: RETINAL SOLUTIONS LLCInventors: Michael T. Trese, Antonio Capone, Kimberly Drenser
-
Patent number: 10669321Abstract: A method is provided for capillary stabilization and vascular regeneration in retinal tissue. Capillary regeneration is accomplished with a protein that is a truncated norrin protein (synthetic). The truncated norrin protein has a longer half-life in the eye than native wild norrin proteins. Specific versions of the truncated norrin protein lack a cleavage site that an enzyme in the eye use to cleave to native norrin proteins and thereby shorten the useful life of the protein. The provided method encourages vascular development with an exogenous treatment of truncated norrin that have been investigated in oxygen-induced retinopathy (OIR) mice. The therapeutic feasibility of intravitreal injection of the norrin protein and its effect on retinal development by activating Wnt-signaling has also been shown.Type: GrantFiled: December 10, 2018Date of Patent: June 2, 2020Assignee: RETINAL SOLUTIONS LLCInventors: Kimberly Drenser, Michael T. Trese, Antonio Capone
-
Publication number: 20190218263Abstract: A method of tightening inter-cellular junctions in retinal or choroidal vessel cells includes exposing the retinal or choroidal vessel cells to norrin and an anti-VEGF agent. Upon sufficient contact time, for norrin to selectively up-regulate gene expression of VE-cadherin or claudin-5 in the retinal or choroidal vessel cells, the inter-cellular junctions are tightened. The method is also suitable for treating retinal pigment epithelial cells in wet macular degeneration.Type: ApplicationFiled: November 6, 2018Publication date: July 18, 2019Inventors: Michael T. Trese, Antonio Capone, Kimberly Drenser
-
Publication number: 20190169247Abstract: A method is provided for capillary stabilization and vascular regeneration in retinal tissue. Capillary regeneration is accomplished with a protein that is a truncated norrin protein (synthetic). The truncated norrin protein has a longer half-life in the eye than native wild norrin proteins. Specific versions of the truncated norrin protein lack a cleavage site that an enzyme in the eye use to cleave to native norrin proteins and thereby shorten the useful life of the protein. The provided method encourages vascular development with an exogenous treatment of truncated norrin that have been investigated in oxygen-induced retinopathy (OIR) mice. The therapeutic feasibility of intravitreal injection of the norrin protein and its effect on retinal development by activating Wnt-signaling has also been shown.Type: ApplicationFiled: December 10, 2018Publication date: June 6, 2019Inventors: Kimberly Drenser, Michael T. Trese, Antonio Capone
-
Publication number: 20190158388Abstract: The apparatus (SW) has a plurality of input/output ports (P1, P2, P3, P4, P5) for receiving and transmitting data packets, and comprises a data packets handling circuitry (DPL) arranged to forward data packets between the input/output ports (P1, P2, P3, P4, P5) and an internal apparatus controller (CPL) arranged to control the data packet handling circuitry (DPL); the apparatus controller (CPL) is arranged to store (MEM) at least one state transition table (TT) to be used for controlling the forwarding of data packets by the data packets handling circuitry (DPL); the apparatus controller (CPL) is arranged to use the state transition table (TT) for implementing at least one finite state machine (FSM); the apparatus controller (CPL) is arranged to use the state transition table (TT) for handling separately distinct incoming data packets flows through corresponding distinct instances of finite state machine; the state transition table (TT) corresponds to the combination of a state table (ST), a condition table (Type: ApplicationFiled: March 27, 2017Publication date: May 23, 2019Applicant: Consorzio Nazionale Interuniversitario Per le Telecpmunicazioni (CNIT)Inventors: Giuseppe BIANCHI, Salvatore PONTARELLI, Marco BONOLA, Carmelo CASCONE, Davide SANVITO, Antonio CAPONE
-
Publication number: 20190105372Abstract: A method of tightening inter-cellular junctions in endothelial or epithelial cells includes exposing the endothelial or epithelial cells to a norrin in concert with an anti-VEGF agent. Upon sufficient contact time, for norrin to selectively up-regulate gene expression of Cadherin or claudin-5 in the endothelial or epithelial cells, the inter-cellular junctions are tightened.Type: ApplicationFiled: December 12, 2018Publication date: April 11, 2019Inventors: Michael T. Trese, Antonio Capone, Kimberly Drenser
-
Patent number: 10110489Abstract: The apparatus (SW) has a plurality of input/output ports (P1, P2, P3, P4, P5) for receiving and transmitting data packets, and comprises a data packets handling circuitry (DPL) arranged to forward data packets between the input/output ports (P1, P2, P3, P4, P5) and an internal apparatus controller (CPL) arranged to control the data packet handling circuitry (DPL); the apparatus (SW) has a control port (PC) for communication between the internal apparatus controller (CPL) and an external network controller (NWC); the apparatus controller (CPL) is arranged to store (MEM) at least one state transition table (TT) to be used for controlling the forwarding of data packets by the data packets handling circuitry (DPL); the apparatus controller (DPL) is arranged to use said at least one state transition table (TT) for implementing at least one finite state machine (FSM); the apparatus controller (DPL) is arranged to use said at least one state transition table (TT) for handling separately distinct incoming data packetType: GrantFiled: March 10, 2015Date of Patent: October 23, 2018Inventors: Giuseppe Bianchi, Antonio Capone, Marco Bonola, Carmelo Cascone
-
Publication number: 20180024138Abstract: A method for determining the necessity of a pre-term birth treatment is provided based on obtaining a biological sample from a subject. The biological sample is analyzed for the presence of (P33S;P168S) Frizzled4 (Fzd4) gene variation. The subject or a fetus thereof is then treated for a proclivity to pre-term birth. The Fzd4 protein itself can also be analyzed for the (P33S;P168S) Fzd4 mutation.Type: ApplicationFiled: July 21, 2017Publication date: January 25, 2018Inventors: Kimberly Drenser, Michael T. Trese, Antonio Capone
-
Publication number: 20170317930Abstract: The apparatus (SW) has a plurality of input/output ports (P1, P2, P3, P4, P5) for receiving and transmitting data packets, and comprises a data packets handling circuitry (DPL) arranged to forward data packets between the input/output ports (P1, P2, P3, P4, P5) and an internal apparatus controller (CPL) arranged to control the data packet handling circuitry (DPL); the apparatus (SW) has a control port (PC) for communication between the internal apparatus controller (CPL) and an external network controller (NWC); the apparatus controller (CPL) is arranged to store (MEM) at least one state transition table (TT) to be used for controlling the forwarding of data packets by the data packets handling circuitry (DPL); the apparatus controller (DPL) is arranged to use said at least one state transition table (TT) for implementing at least one finite state machine (FSM); the apparatus controller (DPL) is arranged to use said at least one state transition table (TT) for handling separately distinct incoming data packetType: ApplicationFiled: March 10, 2015Publication date: November 2, 2017Inventors: Giuseppe Bianchi, Antonio Capone, Marco Bonola, Carmelo Cascone
-
Patent number: 8401020Abstract: Requests of resources of uplink flows towards a base station (BS) and/or downlink flows towards end nodes are computed by each requesting node on an end-to-end basis. Each requesting node issues a cumulative request given by summing up the same request for each link separating the node from the BS plus each link separating the BS from the destination node, enabling the centralized node to perform connection based scheduling. The BS in response to all cumulative requests grants uplink and/or downlink resources for each link. The profile of grants is equal to the profile of requests when the amount of resources requested is below the maximum net throughput on MAC layer. When not below the maximum net through-put on MAC layer, the ideal profile of grants is normalized with respect to a ratio between the maximum net throughput on MAC layer and the amount of the overall requested resources.Type: GrantFiled: June 29, 2006Date of Patent: March 19, 2013Assignee: Siemens S.p.A.Inventors: Antonio Capone, Luca Coletti, Luigi Fratta, Lino Moretti, Simone Redana, Nicola Riato
-
Publication number: 20090296668Abstract: Requests of resources of uplink flows towards a base station (BS) and/or downlink flows towards end nodes are computed by each requesting node on an end-to-end basis. Each requesting node issues a cumulative request given by summing up the same request for each link separating the node from the BS plus each link separating the BS from the destination node, enabling the centralized node to perform connection based scheduling. The BS in response to all cumulative requests grants uplink and/or downlink resources for each link. The profile of grants is equal to the profile of requests when the amount of resources requested is below the maximum net throughput on MAC layer. When not below the maximum net through-put on MAC layer, the ideal profile of grants is normalized with respect to a ratio between the maximum net throughput on MAC layer and the amount of the overall requested resources.Type: ApplicationFiled: June 29, 2006Publication date: December 3, 2009Applicant: SIEMENS S.P.A.Inventors: Antonio Capone, Luca Coletti, Luigi Fratta, Lino Moretti, Simone Redana, Nicola Riato